Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction

NCT04128891 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding not approved

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Sacubitril-Valsartan

Sponsor

Flinders University